Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study.
Romine JK, Li H, Coughlin MM, Jones JM, Britton A, Tyner HL, Fuller SB, Bloodworth R, Edwards LJ, Etolue JN, Morrill TC, Newes-Adeyi G, Olsho LEW, Gaglani M, Fowlkes A, Hollister J, Bedrick EJ, Uhrlaub JL, Beitel S, Sprissler RS, Lyski Z, Porter CJ, Rivers P, Lutrick K, Caban-Martinez AJ, Yoon SK, Phillips AL, Naleway AL, Burgess JL, Ellingson KD. Romine JK, et al. Among authors: olsho lew. Clin Infect Dis. 2024 Jul 19;79(1):96-107. doi: 10.1093/cid/ciae130. Clin Infect Dis. 2024. PMID: 38466720
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
Herring MK, Romine JK, Wesley MG, Ellingson KD, Yoon SK, Caban-Martinez AJ, Meece J, Gaglani M, Grant L, Olsho LEW, Tyner HL, Naleway AL, Khan SM, Phillips AL, Solle NS, Rose S, Mak J, Fuller SB, Hunt A, Kuntz JL, Beitel S, Yoo YM, Zheng PQ, Arani G, Lamberte JM, Edwards T, Thompson MG, Sprissler R, Thornburg NJ, Lowe AA, Pilishvili T, Uhrlaub JL, Lutrick K, Burgess JL, Fowlkes AL. Herring MK, et al. Among authors: olsho lew. Clin Infect Dis. 2023 May 24;76(10):1822-1831. doi: 10.1093/cid/ciac976. Clin Infect Dis. 2023. PMID: 36578137
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Ellingson KD, Hollister J, Porter CJ, Khan SM, Feldstein LR, Naleway AL, Gaglani M, Caban-Martinez AJ, Tyner HL, Lowe AA, Olsho LEW, Meece J, Yoon SK, Mak J, Kuntz JL, Solle NS, Respet K, Baccam Z, Wesley MG, Thiese MS, Yoo YM, Odean MJ, Miiro FN, Pickett SL, Phillips AL, Grant L, Romine JK, Herring MK, Hegmann KT, Lamberte JM, Sokol B, Jovel KS, Thompson MG, Rivers P, Pilishvili T, Lutrick K, Burgess JL, Midgley CM, Fowlkes AL. Ellingson KD, et al. Among authors: olsho lew. Emerg Infect Dis. 2023 Mar;29(3):599-604. doi: 10.3201/eid2903.221314. Epub 2023 Jan 26. Emerg Infect Dis. 2023. PMID: 36703252 Free PMC article.
Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections.
Quirk GE, Schoenle MV, Peyton KL, Uhrlaub JL, Lau B, Burgess JL, Ellingson K, Beitel S, Romine J, Lutrick K, Fowlkes A, Britton A, Tyner HL, Caban-Martinez AJ, Naleway A, Gaglani M, Yoon S, Edwards L, Olsho L, Dake M, LaFleur BJ, Nikolich JŽ, Sprissler R, Worobey M, Bhattacharya D. Quirk GE, et al. medRxiv [Preprint]. 2023 Sep 14:2023.09.12.23295384. doi: 10.1101/2023.09.12.23295384. medRxiv. 2023. PMID: 37745498 Free PMC article. Preprint.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Steinhardt L, Tyner H, Vandermeer M, Vaughan M, Yoon SK, Gaglani M, Naleway AL. Feldstein LR, et al. Among authors: olsho lew. JAMA. 2024 Feb 6;331(5):408-416. doi: 10.1001/jama.2023.27022. JAMA. 2024. PMID: 38319331 Free PMC article.
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
Yoon SK, Hegmann KT, Thiese MS, Burgess JL, Ellingson K, Lutrick K, Olsho LEW, Edwards LJ, Sokol B, Caban-Martinez AJ, Schaefer-Solle N, Jones JM, Tyner H, Hunt A, Respet K, Gaglani M, Dunnigan K, Rose S, Naleway A, Groom H, Kuntz J, Fowlkes AL, Thompson MG, Yoo YM; HEROES-RECOVER Network Investigators; HEROES-RECOVER Network Investigators. Yoon SK, et al. Among authors: olsho lew. N Engl J Med. 2022 May 12;386(19):1855-1857. doi: 10.1056/NEJMc2201821. Epub 2022 Apr 6. N Engl J Med. 2022. PMID: 35385628 Free PMC article. No abstract available.
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.
Hollister J, Porter C, Sprissler R, Beitel SC, Romine JK, Uhrlaub JL, Grant L, Yoo YM, Fowlkes A, Britton A, Olsho LEW, Newes-Adeyi G, Fuller S, Zheng PQ, Gaglani M, Rose S, Dunnigan K, Naleway AL, Gwynn L, Caban-Martinez A, Schaefer Solle N, Tyner HL, Philips AL, Hegmann KT, Yoon S, Lutrick K, Burgess JL, Ellingson KD. Hollister J, et al. Among authors: olsho lew. PLoS One. 2024 Dec 31;19(12):e0306953. doi: 10.1371/journal.pone.0306953. eCollection 2024. PLoS One. 2024. PMID: 39739951 Free PMC article.
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers.
Mak J, Khan S, Britton A, Rose S, Gwynn L, Ellingson KD, Meece J, Feldstein L, Tyner H, Edwards L, Thiese MS, Naleway A, Gaglani M, Solle N, Burgess JL, Lamberte JM, Shea M, Hunt-Smith T, Caban-Martinez A, Porter C, Wiegand R, Rai R, Hegmann KT, Hollister J, Fowlkes A, Wesley M, Philips AL, Rivers P, Bloodworth R, Newes-Adeyi G, Olsho LEW, Yoon SK, Saydah S, Lutrick K. Mak J, et al. Among authors: olsho lew. J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093/infdis/jiae556. Online ahead of print. J Infect Dis. 2024. PMID: 39531735
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
HEROES-RECOVER Network; Thompson MG, Yoon SK, Naleway AL, Meece J, Fabrizio TP, Caban-Martinez AJ, Burgess JL, Gaglani M, Olsho LEW, Bateman A, Lundgren J, Grant L, Phillips AL, Groom HC, Stefanski E, Solle NS, Ellingson K, Lutrick K, Dunnigan K, Wesley MG, Guenther K, Hunt A, Mak J, Hegmann KT, Kuntz JL, Bissonnette A, Hollister J, Rose S, Morrill TC, Respet K, Fowlkes AL, Thiese MS, Rivers P, Herring MK, Odean MJ, Yoo YM, Brunner M, Bedrick EJ, Fleary DE, Jones JT, Praggastis J, Romine J, Dickerson M, Khan SM, Lamberte JM, Beitel S, Webby RJ, Tyner HL. HEROES-RECOVER Network, et al. Among authors: olsho lew. JAMA. 2022 Oct 18;328(15):1523-1533. doi: 10.1001/jama.2022.18550. JAMA. 2022. PMID: 36255426 Free PMC article.
35 results